Xeris Pharmaceuticals | XERS - Pre Tax Profit


Xeris Pharmaceuticals reported $2.23M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Celltrion KRW 11.84B 1.34B Mar/2026
Cspc Pharmaceutical CNY 505.59M 706M Dec/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Divis Laboratories Ltd INR 11.8B 2.17B Jun/2026
Eli Lilly USD 8.85B 583.8M Mar/2026
Kangmei Pharma CNY -14.01M 16.08M Mar/2026
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
Medical Developments International AUD -149K 466K Jun/2025
Nektar Therapeutics USD -43.09M 8.39M Mar/2026
Neuren Pharmaceuticals AUD 19.21M 9.35M Dec/2025
Organigram Holdings CAD -921K 40.8M Mar/2026
Pacira USD 5M 4.43M Mar/2026
Perrigo USD 105.4M 513.9M Jun/2026
Pharma Mar EUR -993K 2.59M Jun/2026
Qiagen NV USD 157.9M 72.08M Jun/2026
Sartorius EUR 127M 30.8M Jun/2026
Supernus Pharmaceuticals USD -57.65M 51.7M Jun/2026
Tilray USD -39.96M 39.19M Sep/2025
Zealand Pharma A/S -394M 12.5M Mar/2026
Zz Pientze Pharmaceu CNY 876.07M 352.96M Mar/2026